Verastem (VSTM) Common Equity (2011 - 2026)

Verastem's Common Equity history runs 16 years deep, the most recent figure standing at $81.8 million for Q1 2026.

• In Q1 2026, Common Equity rose 352.14% year-over-year to $81.8 million; the TTM figure through Mar 2026 stood at $81.8 million (up 352.14% YoY), while the FY2025 annual figure was $57.2 million, up 297.96% from the prior year.
• Common Equity for Q1 2026 stood at $81.8 million, up from $57.2 million in the prior quarter.
• The five-year high for Common Equity was $101.6 million in Q2 2023, with the low at -$32.4 million in Q1 2025.
• The 5-year median for Common Equity is $47.4 million (2022), against an average of $39.1 million.
• The sharpest annual moves came in 2025 and 2026: Common Equity tumbled 240.38% in 2025, then surged 352.14% in 2026.
• Verastem's Common Equity stood at $47.4 million in 2022, then gained by 21.07% to $57.4 million in 2023, then plunged by 150.36% to -$28.9 million in 2024, then soared by 297.96% to $57.2 million in 2025, then jumped by 42.97% to $81.8 million in 2026.
• Business Quant data shows VSTM's Common Equity at $81.8 million in Q1 2026, $57.2 million in Q4 2025, and -$15.5 million in Q3 2025.